Panacea Biotec
From Wikipedia, the free encyclopedia
 |
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2011) |
| Type | Public |
|---|---|
| Industry | Pharmaceutical industry |
| Headquarters | New Delhi, India |
| Key people | Soshil Kumar Jain (Executive Chairman of the Board, Ravinder Jain (Managing Director), Dr. Rajesh Jain (Joint Managing Director) |
| Products | Pharmaceuticals, generic drugs, vaccine |
| Website | www.panacea-biotec.com |
Panacea Biotec is an Indian research based pharmaceutical and health management company involved in research, manufacturing, and marketing of pharmaceutical formulations, vaccines, and natural products.[1] It is one of the three largest biotech companies in India.[2] In August 2011 several of its hepatitis vaccines were removed from the list of prequalified vaccines by the World Health Organization[3] because of quality management issues, but the issues were expected to be resolved by early 2012.[4]
Panacea Biotec has 5 research centres across India that specialize in the fields of pharmaceuticals, biotechnology, natural products and biopharmaceutics.
[edit] References
- ^ "New vaccines to lift sales at Panacea Biotec". International Herald Tribune. 18 August 2005. http://www.iht.com/articles/2005/08/17/bloomberg/sxbio.php. Retrieved 2009-03-05.
- ^ Risky Business, Express Pharma, December 2, 2011
- ^ "Bharat Biotech gets WHO blow over Hep-B vaccine", The Times of India, December 15, 2011
- ^ equitybulls.com
